ATE497745T1 - Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren - Google Patents

Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren

Info

Publication number
ATE497745T1
ATE497745T1 AT05771439T AT05771439T ATE497745T1 AT E497745 T1 ATE497745 T1 AT E497745T1 AT 05771439 T AT05771439 T AT 05771439T AT 05771439 T AT05771439 T AT 05771439T AT E497745 T1 ATE497745 T1 AT E497745T1
Authority
AT
Austria
Prior art keywords
sustained release
progesterone receptor
release compositions
compositions containing
receptor modulators
Prior art date
Application number
AT05771439T
Other languages
English (en)
Inventor
Regine Sitruk-Ware
Yun-Yen Tsong
Original Assignee
Population Council Inc
Hra Pharma Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc, Hra Pharma Lab filed Critical Population Council Inc
Application granted granted Critical
Publication of ATE497745T1 publication Critical patent/ATE497745T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT05771439T 2004-07-09 2005-07-08 Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren ATE497745T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58678304P 2004-07-09 2004-07-09
PCT/US2005/024474 WO2006010097A2 (en) 2004-07-09 2005-07-08 Sustained release compositions containing progesterone receptor modulators

Publications (1)

Publication Number Publication Date
ATE497745T1 true ATE497745T1 (de) 2011-02-15

Family

ID=35785781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05771439T ATE497745T1 (de) 2004-07-09 2005-07-08 Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren

Country Status (16)

Country Link
US (1) US8865200B2 (de)
EP (1) EP1768625B1 (de)
JP (2) JP5017109B2 (de)
KR (1) KR101229701B1 (de)
CN (1) CN101080205B (de)
AT (1) ATE497745T1 (de)
AU (1) AU2005265357B2 (de)
BR (1) BRPI0513141A (de)
CA (1) CA2573266C (de)
DE (1) DE602005026290D1 (de)
DK (1) DK1768625T3 (de)
ES (1) ES2360806T3 (de)
MX (1) MX2007000273A (de)
NZ (1) NZ552720A (de)
PT (1) PT1768625E (de)
WO (1) WO2006010097A2 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US8399013B2 (en) 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
US8404272B2 (en) 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US8062658B2 (en) * 2004-12-14 2011-11-22 Poly-Med, Inc. Multicomponent bioactive intravaginal ring
EP1862468A1 (de) 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
EP2037938A2 (de) * 2006-07-12 2009-03-25 Controlled Therapeutics (Scotland) Ltd. Arzneiabgabe-polymer mit clindamycin-hydrochloridsalz
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
ES2814343T3 (es) * 2006-10-24 2021-03-26 Allergan Pharmaceuticals Int Ltd Composiciones y métodos para suprimir las proliferaciones endometriales
JP5785392B2 (ja) 2007-04-20 2015-09-30 プレグレム エスアーＰｒｅｇｌｅｍ Ｓ．Ａ． 過剰子宮出血の治療におけるプロゲステロンアンタゴニストおよび選択的プロゲステロンモジュレーター
US8299050B2 (en) 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
PT2249757T (pt) 2008-02-04 2017-11-15 Ferring Bv Anéis intravaginais monolíticos compreendendo progesterona e métodos de preparação e suas utilizações
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
US9034365B2 (en) 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
EP3106167A1 (de) 2009-04-14 2016-12-21 Laboratoire HRA Pharma Verfahren zur bedarfsabhängigen kontrazeption
WO2010119030A1 (en) 2009-04-14 2010-10-21 Ulmann Andre Method for on-demand contraception using levonorgestrel or norgestrel
US20120070476A1 (en) * 2009-05-29 2012-03-22 Moench Thomas R Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
JP5894143B2 (ja) * 2010-03-22 2016-03-23 リプロス セラピューティクス インコーポレイテッド 抗黄体ホルモンの無毒送達のための組成物および方法
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102011004899A1 (de) 2011-03-01 2012-09-06 Bayer Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE202011110355U1 (de) * 2011-03-09 2014-01-15 Arstat, Inc. Behandlung von Uterusmyomen durch intravaginale Verabreichung einer niedrigen Dosis eines selektiven Progesteronrezeptormodulators, eines Antigestagens oder eines Antigestagen-Wirkstoffes
EP2545922A1 (de) 2011-07-12 2013-01-16 PregLem S.A. Behandlung von übermäßiger Monatsblutung im Zusammenhang mit Gebärmutterfibromen
IL215224A0 (en) * 2011-09-18 2012-02-29 Katz Daniel Dr Vaginal danazol combined with non steroidal anti inflammatory drugs (nsaids) compositions
JP5902318B2 (ja) * 2011-12-29 2016-04-13 ラボラトリオス アンドロマコ ソシエダッド アノニマ メロキシカム、および有効成分の放出を調節する薬剤を含み、女性における連続使用避妊に用いられることができる膣リング
FR2987271B1 (fr) * 2012-02-28 2017-08-18 Hra Pharma Lab Combinaison de modulateurs selectifs du recepteur a la progesterone et d'anti-inflammatoires non steroidiens
EP2641602A1 (de) 2012-03-23 2013-09-25 PregLem S.A. Verfahren zur Behandlung gynäkologischer Leiden
JP6341910B2 (ja) 2012-05-31 2018-06-13 レプロス セラピューティクス インコーポレイティド 抗プロゲスチンの経膣送達用製剤およびその送達方法
JP6200493B2 (ja) * 2012-09-28 2017-09-20 あすか製薬株式会社 無定形ウリプリスタール酢酸エステル
MX2015004821A (es) 2012-11-02 2015-08-14 Repros Therapeutics Inc Metodos y composiciones para tratar condiciones dependientes de la progesterona.
FR2997627B1 (fr) 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
FR2997628B1 (fr) 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone
FR2999081B1 (fr) 2012-12-06 2015-02-27 Hra Pharma Lab Dispersion solide d'un modulateur selectif du recepteur a la progesterone
JP6249790B2 (ja) 2013-01-29 2017-12-20 三菱鉛筆株式会社 シャープペンシル
BR112015025954A2 (pt) 2013-04-10 2017-07-25 Preglem Sa moduladores do receptor de progesterona para utilização na terapia de fibroides uterinos
EP2983671B1 (de) 2013-04-11 2018-10-24 Bayer Pharma Aktiengesellschaft Dosierungsform für einen progesteron-rezeptorantagonisten
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
DE102014004388A1 (de) * 2014-03-26 2015-10-01 Angela Kayser Verfahren und System zum intravaginalen Verabreichen von Progesteron
PT3125964T (pt) * 2014-04-01 2024-09-09 Poly Med Inc Contracetivo e dispositivo relacionado
PL2982352T3 (pl) 2014-06-28 2019-01-31 Laboratorios Andrómaco S.A. Krążek szyjki macicy zawierający progesteron do długotrwałego, przedłużonego i ciągłego uwalniania, stosowany w celu zapobiegania przed przedwczesnym porodem
CN113559075A (zh) 2014-11-17 2021-10-29 康泰科思特生物制药公司 奥那司酮延长释放组合物和方法
CA2998924A1 (en) 2015-09-25 2017-03-30 Context Biopharma Inc. Methods of making onapristone intermediates
JP2019503353A (ja) * 2015-12-15 2019-02-07 コンテキスト・バイオファーマ・インコーポレイテッド 非晶質オナプリストン組成物およびそれを作製する方法
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
CN114073792A (zh) * 2020-08-11 2022-02-22 上海市生物医药技术研究院 含来曲唑的阴道环、其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5211952A (en) 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
PT900234E (pt) 1996-05-01 2000-12-29 Us Gov Health & Human Serv Derivados de progesterona substituidos em 21 que podem ser utilizados como novos agentes antiprogestativos
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6358947B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
FR2822022B1 (fr) 2001-03-19 2005-11-04 Atofina Traitement pesticide des sols agricoles avec des composes soufres
CN1210079C (zh) * 2001-04-25 2005-07-13 上海市计划生育科学研究所 阴道环制剂及其应用
CA2523859C (en) 2003-04-29 2011-08-02 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
GT200500186A (es) 2004-07-07 2006-03-02 Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits

Also Published As

Publication number Publication date
AU2005265357B2 (en) 2011-04-07
PT1768625E (pt) 2011-04-18
DK1768625T3 (da) 2011-05-09
JP5017109B2 (ja) 2012-09-05
MX2007000273A (es) 2007-05-21
CN101080205A (zh) 2007-11-28
DE602005026290D1 (de) 2011-03-24
AU2005265357A1 (en) 2006-01-26
EP1768625B1 (de) 2011-02-09
CA2573266C (en) 2011-11-08
JP2008505718A (ja) 2008-02-28
EP1768625A4 (de) 2008-07-09
CN101080205B (zh) 2011-10-12
JP2012040400A (ja) 2012-03-01
NZ552720A (en) 2010-02-26
WO2006010097A2 (en) 2006-01-26
ES2360806T3 (es) 2011-06-09
EP1768625A2 (de) 2007-04-04
WO2006010097A3 (en) 2006-08-10
KR101229701B1 (ko) 2013-02-05
BRPI0513141A (pt) 2008-04-29
US20080199511A1 (en) 2008-08-21
KR20070044005A (ko) 2007-04-26
US8865200B2 (en) 2014-10-21
CA2573266A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
ATE497745T1 (de) Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren
TW200607798A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
ATE502640T1 (de) Allosterische a3-adenosin-rezeptormodulatoren
CR7611A (es) Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona
MX2007004862A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias.
MX366832B (es) Composiciones de farmaco de liberacion sostenida convenientemente implantables.
MX339797B (es) Terapia ocular que usa derivados glucocorticoides que penetran selectivamente los tejidos del segmento posterior.
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
UA94600C2 (en) Indole sulfonamide modulators of progesterone receptors
TW200621235A (en) Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
TW200606146A (en) Novel indole derivatives as selective androgen receptor modulators (SARMS)
SI1989218T1 (sl) 17- fosforjevi steroidni derivati, koristni kot progesteronski receptorski modulatorji
PE20151783A1 (es) Dispersion solida de un modulador selectivo de los receptores de progesterona
WO2006066011A3 (en) Compounds and compositions as modulators of steroidal receptors and calcium channel activities
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
TW200604171A (en) Novel indole derivatives as selective androgen receptor modulators (SARMs)
WO2008113851A3 (en) Novel c11 modified retrosteroids as progesterone receptor modulator compounds
DK1525215T3 (da) Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner
ECSP088147A (es) Moduladores del receptor de la cianopirrol-sulfonamida progesterona y los usos de los mismos
AU2003256882A1 (en) Methods of drug delivery using sulphated chitinous polymers
DK1732921T3 (da) Thiomidderivater som progesteronreceptormodulatorer
UA88303C2 (ru) Производные пиперидина, которые имеют активность по отношению к ccr5 (хемокинового рецептора 5)
BRPI0507987A (pt) métodos e compostos moduladores receptor de glicocorticóide
EA200702604A1 (ru) Производные бензофуранона как нестероидные модуляторы рецептора прогестерона

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1768625

Country of ref document: EP